Temgesic is primarily used for the short-term relief of moderate to severe pain, especially when other treatment options have failed, are contraindicated, not tolerated, or otherwise inappropriate[1][2][3][5][6]. It contains the active ingredient buprenorphine, an opioid (narcotic) analgesic which acts directly on the brain and spinal cord to block the sensation of pain[2][5].
Temgesic is clinically indicated for:
- Short-term (not more than one week) management of severe pain[3][6]
- Relief of moderate to severe pain, usually when other painkillers have not been effective or are unsuitable[1][5]
Temgesic is not recommended for use in children and does not have an approved role in opioid dependence rehabilitation programs[3].
It is administered as a sublingual tablet (dissolved under the tongue) and is typically prescribed in a dosage of 1–2 tablets (200–400 micrograms) every 6–8 hours, or as required[1][5].
Leave a Reply